First, we verified that DNMT1 and DNMT3A were highly expressed in a panel of human HCC cell lines, especially those with an HBV-positive background, such as HepG2.2.15, PLC/PRF/5, and Hep3B (Fig. S2A). Here, DNMT3A is linked to hepatocellular carcinoma.